Renal Sarcoidosis with Significant Hypercalcemia (Ca >11 mg/dl) or Nephrolithiasis: What to Do When Initial Treatment Has Not Worked

Clinical Scenario

This protocol is for patients with renal sarcoidosis who present with significant hypercalcemia — serum calcium greater than 11 mg/dl — or nephrolithiasis. This degree of calcium dysregulation represents a more severe presentation that requires an escalated treatment strategy.

When the Previous Treatment Step Falls Short

This protocol comes into play after Hydroxychloroquine (with ketoconazole as an adjunct targeting hypercalcemia and hypercalciuria) has not achieved normalization of serum calcium and urine calcium. Failure to reach those targets is the trigger for advancing to this next treatment line.

Next-Line Treatment Approach

Management at this stage centres on cytotoxic drug therapy. Which agent applies — and under what conditions — is determined by individual clinical factors; the complete selection framework is available in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

For more significant hypercalcemia (e.g. Ca >11 mg/dl) or nephrolithiasis, corticosteroid therapy is usually implemented at 20-40 mg daily.

Cytotoxic drugs include: methotrexate, azathioprine, mycophenolate and leflunomide.

View source ↗